Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF in Adolescents with Chronic Hepatitis B
NCT00734162Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Dec 2008; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00734162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734162.